LionLion Corporation4912東証プライム化学FY ending Dec 2025, consolidated, IFRS
About 63% of Lion's sales come from General-use consumable products business, with Overseas business and Industrial products business making up much of the rest.
Out of every ¥100 of sales, about ¥9 is left as operating profit.
Revenue changed +3.1% from the prior year, operating profit -29.3%.
Revenue +3.1% · profit -29.3%, calculated from disclosed figures.
Operating leverage: -9.55× (profit growth ÷ revenue growth)
FY ending Dec 2020 → FY ending Dec 2021
FY ending Dec 2020 → FY ending Dec 2021
For every ¥100 Lion sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segments without disclosed profit are drawn entirely as costs
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書-第165期(2025/01/01-2025/12/31)
EDINET (FSA Japan)
有価証券報告書-第164期(2024/01/01-2024/12/31)
EDINET (FSA Japan)
有価証券報告書-第163期(2023/01/01-2023/12/31)
EDINET (FSA Japan)
有価証券報告書-第162期(2022/01/01-2022/12/31)
EDINET (FSA Japan)
有価証券報告書-第161期(令和3年1月1日-令和3年12月31日)
EDINET (FSA Japan)
有価証券報告書-第160期(令和2年1月1日-令和2年12月31日)
Extracted from XBRL: 44 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.